Long-term cost-effectiveness of early and sustained clopidogrel therapy for up to 1 year in patients undergoing percutaneous coronary intervention after presenting with acute coronary syndromes without ST-segment elevation

American Heart Journal

Volumn 151, Issue 1, 2006, Pages 219-227

  Mahoney, Elizabeth M ^a   Mehta, Shamir ^b   Yuan, Yong ^c   Jackson, Joseph ^c   Chen, Roland ^c   Gabriel, Sylvie ^d   Lamy, Andre ^b   Culler, Steven ^e   Caro, Jaime ^f   Yusuf, Salim ^b   Weintraub, William S ^e  

^a NEW ENGLAND RESEARCH INSTITUTES   (United States)

^b MCMASTER UNIVERSITY   (Canada)

^c BRISTOL MYERS SQUIBB   (United States)

^d SANOFI   (France)

^e EMORY UNIVERSITY   (United States)

^f CARO RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLOPIDOGREL;

ACUTE HEART FAILURE; ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; EVALUATION; FEMALE; HOSPITALIZATION; HUMAN; LIFE EXPECTANCY; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; ST SEGMENT ELEVATION;

ACUTE DISEASE; AGED; ANGINA, UNSTABLE; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; COST-BENEFIT ANALYSIS; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PLATELET AGGREGATION INHIBITORS; RANDOMIZED CONTROLLED TRIALS; SYNDROME; TICLOPIDINE; TIME FACTORS;

EID: 29144445907     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2005.02.044     Document Type: Article

References (17)

1. S. Yusuf, F. Zhao, and S.R. Mehta Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation N Engl J Med 345 2001 494 502
2. S.R. Mehta, S. Yusuf, and R.J.G. Peters Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE Study Lancet 358 2001 527 533
3. E. Braunwald, E.M. Antman, and J.W. Beasley ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction-summary article: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee on the Management of Patients With Unstable Angina) J Am Coll Cardiol 40 2002 1366 1374
4. Centers for Medicare and Medicaid Services. www.cms.gov/statistics/ medpar/shtstay01drg.pdf [accessed 11/25/2003].
5. The MEDSTAT Groups DRG guide: descriptions and normative values 1994 Ann Arbor
6. J. Mitchell, R. Burge, and A. Lee Per case prospective payment for episodes of hospital care 1995 US Department of Commerce National Technical Information Service Springfield (VA) [Publication PB95226023]
7. J.J. Caro, K. Migliaccio-Walle, and J. Ishak Estimating life-years lost due to atherothrombotic events: flexible survival functions for use in disease modeling J Am Coll Cardiol 43 Suppl A 2004 425A
8. A. Peeters, A.A. Mamun, and F. Willekens A cardiovascular life history. A life course analysis of the original Framingham Heart Study cohort Eur Heart J 23 2002 458 466
9. E.M. Mahoney, C.T. Jurkovitz, and H. Chu Cost and cost-effectiveness of an early invasive vs conservative strategy for the treatment of unstable angina and non-ST-segment elevation myocardial infarction JAMA 288 2002 1851 1858
10. B. Efron, and R. Tibshirani An introduction to the bootstrap 1993 Chapman and Hall New York
11. R.B. D'Agostino Propensity score methods for bias reduction in the comparison of treatment to a non-randomized control group Stat Med 17 1998 2265 2281
12. J.S. Hoch, A.H. Briggs, and A.R. Willan Something old, something new, something borrowed, something blue: a framework for the marriage of health econometrics and cost-effectiveness analysis Health Econ 11 2002 415 430
13. B.A. Van Hout, M.J. Al, and G.S. Gordon Costs, effects and C/E-ratios alongside a clinical trial Health Econ 3 1994 309 319
14. D.B. Mark, R.A. Harrington, and M. Lincoff Cost-effectiveness of platelet glycoprotein IIb/IIIa inhibition with eptifibatide in patients with non-ST elevation acute coronary syndromes Circulation 101 2000 366 371
15. H.M. Krumholz, R.C. Pasternak, and M.C. Weinstein Cost effectiveness of thrombolytic therapy with streptokinase in elderly patients with suspected acute myocardial infarction N Engl J Med 327 1992 7 13
16. M. Johannesson, B. Jonsson, and J. Kjekshus Cost effectiveness of simvastatin treatment to lower cholesterol levels in patients with coronary heart disease N Engl J Med 336 1997 332 336
17. H.M. Krumholz, B.J. Cohen, and J. Tsevat Cost-effectiveness of a smoking cessation program after myocardial infarction J Am Coll Cardiol 22 1993 1697 1702